AIFA makeover: Italy’s leap into 2024
Explore AIFA’s regulatory transformation.
CertaraOctober 4, 2024
How to Use CDISC’s ODM Standard for CRF Design
Over the last decade, our industry has become familiar with Clinical Data Interchange Standards Consortium…
CertaraSeptember 25, 2024
How Clinical Trial Technology Streamlines the Research Process
Learn how innovative clinical trial technology helps to revolutionize research & ensure the swift rollout…
CertaraSeptember 25, 2024
Why cancer drug programs need human mass balance studies
Historically, drug programs for oncology and other rapidly fatal diseases didn’t include mass balance studies…
CertaraSeptember 23, 2024
All You Need to Know About Non-CRF Data in Clinical Trials
We look at the role of non-CRF data in clinical trials, and best practices for…
CertaraSeptember 16, 2024
Why Should You Use LOINC Codes For SDTM?
September 16, 2024 In this blog, we take a detailed look at LOINC Codes and…
CertaraSeptember 16, 2024
The SDTM Mapping Process Simplified
SDTM mapping can be one of the most challenging programming problems in a clinical trial…
CertaraSeptember 16, 2024
What Are SDTM Supplemental Qualifiers?
A detailed look at data that exists out with SDTM variables, known as SDTM supplemental…
CertaraSeptember 16, 2024
4 Ways That Mechanistic Modeling Accelerates Bispecific (and Multispecific) Antibody Drug Development
With nine FDA-approved drugs today, 100+ in clinical development and several hundred in the preclinical…
CertaraSeptember 12, 2024
How has the Inflation Reduction Act Impacted the Biosimilars Market?
The Inflation Reduction Act (IRA), one of the key legislative achievements the Biden-Harris administration, aims…
CertaraAugust 27, 2024
